Author: Phil Baumann

  • Making Sense of Social Media Conversations

    Making Sense of Social Media Conversations

    Phil highlights the relevance of social media monitoring and engagement in the healthcare industry.

  • Pharma’s Next Step: Tapping into Social Media to Support Critical Initiatives

    Pharma’s Next Step: Tapping into Social Media to Support Critical Initiatives

    Increase in social media adoption by both patients and physicians is beginning to catch the attention of market leaders within the pharmaceutical industry. While there is undoubtedly greater interest in utilizing social media capabilities, many pharmaceutical manufacturers are struggling to understand how social media activities support their core business goals. There is one primary consideration…

  • FDA Webinar on Social Media Guidance

    FDA Webinar on Social Media Guidance

    The FDA held a webinar last week regarding their recently-issued Social Media Guidance documents. Though many who registered were unable to access the webinar due to technical difficulties, the presentations slides and Q&A document were posted to the FDA website. In reviewing the slides, there were no major revelations presented during the webinar and our…

  • 5 Best Practices for Pharma Social Media

    5 Best Practices for Pharma Social Media

    The FDA’s most recent guidance has sparked lots of questions and conversations about how Pharmaceutical companies can effectively use social media. Given the regulatory challenges in social media, here are 5 best practices for pharmaceutical companies interested in using social media: Identify clear and specific objectives that lend themselves to social media outlets: Activities such…